10岁以上儿童及青少年新诊断ALL患者治疗方案选择及预后影响因素分析.pdfVIP

134金晟娴，等10岁以上儿童及青少年新诊断ALL患者治选降及后

影响因素分析

tinibcombinedwithchemotherapyinthetreatmentofadvancedHebeiMedicine,2021,43(7):1082-1086.

gastriccarcinoma:arandomisedcontrolledtrial[J].JournalofOn-[12]PEREIRAMA,BATISTAD,RAMOSM,etal.Epstein-barrvi-

cology,2021,2021:5177140.ruspositivegastriccancer:adistinctsubtypecandidateforimmu-

[7]KOCHINGCHUNG,YEHLEEREN,KUOYUTING,etal.Imagingnotherapy[J].JournalofSurgicalResearch,2021,261:130-

biomarkersforevaluatingtumorresponse:RECISTandbeyond[J].138.

BiomarkerResearch,2021,9(1):52.[13]JOSEPHCHAO,CHARLESSFUCHS,KOHEISHITARA,etal.

[8]KANGYK,BOKUN,SATOHT,etal.NivolumabinpatientswithAssessmentofpembrolizumabtherapyforthetreatmentofmicrosa-

advancedgastricorgastro-oesophagealjunctioncancerrefractorytelliteinstability-highgastricorgastroesophagealjunctioncancer

to,orintolerantof,atleasttwopreviouschemotherapyregimensamongpatientsintheKEYNOTE-059,KEYNOTE-061,and

(ONO-4538-12,ATTRACTION-2):arandomised,double-KEYNOTE-062clinicaltrials[J].JAMAOncology,2021,7

blind,placebo-controlled,phase3trial[J].TheLancet,2017,(6):895-902.

390(10111):2461-2471.[14]田春艳,尹进波,许丰铭,等.阿帕替尼联合免疫调节剂治疗晚

[9]沈仕俊,甘平,王园园,等.PD-1/PD-L1通路抑制剂治疗进期胃癌的效果观察［J].浙江医学,2018,40(9）:996－997.

TIANCY,YINJB,XUFM,etal.Observedtheeffectofapatinib

展期胃癌的研究进展[J